G8977 HCPCS: Oncology Measures Reimbursement

HCPCS Level II code G8977 signals the intent to report the oncology measures group and is used to identify submission of oncology-related quality measures. Nationally, oncology quality reporting informs performance measurement, compliance with payer and regulatory programs, and aggregation of outcomes for cancer care. Use of G8977 matters for health systems, oncology practices, and payers tracking adherence to evidence-based care and quality programs.

Key payers relevant to this code include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks for reporting rates and payer coverage approaches, summaries of any recent policy updates affecting oncology measure reporting, and the clinical context for why oncology measure submission is tracked. The publication outlines typical sites of service and administrative workflows tied to oncology quality reporting and highlights implications for clinical documentation and registry submission.

This summary provides a national perspective on the role of G8977 in oncology quality programs, what organizations should account for when reporting oncology measures, and where to look for payer-specific guidance or registry requirements. Data not available in the input are noted where applicable.

Billing Code Overview

HCPCS Level II code G8977 indicates intent to report the oncology measures group. This code represents the reporting designation for oncology-related quality or performance measures rather than a discrete clinical procedure.

Service type: Quality reporting/registry submission related to oncology measures
Typical site of service: Administrative or clinical settings where oncology quality reporting occurs, including hospital oncology departments, outpatient cancer centers, and clinician offices involved in oncology care

Data not available in the input.

Clinical Context

A 62-year-old patient with a recent diagnosis of stage II colorectal adenocarcinoma is managed by a multidisciplinary oncology team. The patient presents to the cancer center for quality measurement reporting and registry abstraction related to oncology care delivery. The visit includes review of diagnostic workup, documentation of pathology and staging, discussion of treatment intent (surgery and adjuvant chemotherapy), and capture of performance measures for oncology care quality programs. Clinical workflow involves the oncology nurse navigator and clinical documentation specialist abstracting measure data from the electronic health record, confirming treatment dates and intent, and submitting measure group reporting through the facility’s quality reporting portal.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure	Use when a qualifying E/M is provided on the same day as another procedure and is distinctly documented
`59`	Distinct procedural service	Use when procedures not normally reported together are performed at different anatomic sites or separate sessions

Taxonomy Code	Specialty	Notes
`207Q00000X`	Medical Oncology	Primary specialty managing systemic cancer therapy and quality reporting
`207L00000X`	Hematology/Oncology	Common combined specialty for oncology clinics and measure abstraction
`208VP0000X`	Surgical Oncology	Surgeon responsible for staging and operative treatment contributing to oncology metrics
`363LP0808X`	Oncology Nursing	Nurse navigators and oncology certified nurses performing documentation and coordination
`261QM0800X`	Clinical Documentation Specialist	Professional focusing on accurate abstraction and quality measure reporting

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C18.9`	Malignant neoplasm of colon, unspecified	Common diagnosis in oncology measure groups for colorectal cancer care pathways and reporting
`C19`	Malignant neoplasm of rectosigmoid junction	Relevant for staging, treatment planning, and measure capture in colorectal oncology
`C20`	Malignant neoplasm of rectum	Frequently used when reporting outcomes and adherence to colorectal cancer quality measures
`Z85.038`	Personal history of malignant neoplasm of large intestine	Important for surveillance measures and documentation of prior cancer history
`D63.0`	Anemia in neoplastic disease	Common comorbidity documented in oncology patients and relevant to treatment tolerance and measures

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	Often documented on the same day as measure abstraction visits for treatment planning and follow-up
`88305`	Level IV surgical pathology, gross and microscopic examination	Used for pathologic evaluation that informs staging and quality reporting in oncology
`77336`	Radiation treatment delivery, complex conformal therapy, per fraction	Applicable when radiation therapy is part of the oncology care plan documented in measure reporting
`96413`	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug	Used when documenting systemic therapy events that feed into oncology measure group reporting
`99174`	Moderate sedation services provided by the same physician performing the diagnostic or therapeutic service	Applied when procedures requiring sedation are performed and must be captured in the care episode

OpenPayer

Summary & Overview

HCPCS G8977: Oncology Measures Group Reporting